Skip to main content

Distinguished Speaker Series | Doug Gould, PhD

-
Location
https://ucihealth.zoom.us/j/94483669170?pwd=WUd1clg2aUM1bnpPVHd3MlkwTUN1Zz09
Event Type

Add to Calendar: Outlook | Google | iCal

The Center for Translational Vision Research Distinguished Speaker Series, also known as "Friday Seminars" showcases innovative research across the world. The seminar series has now been expanded to include lectures by experts on topics ranging from Ophthalmology, Genetics, Biochemistry, Neurobiology, Imaging, Computational Sciences to Novel Ophthalmic Treatments.

All talks are hybrid. You can join us in person at

The Susan & Henry Samueli College of Health Sciences 

Sue Gross Auditorium.

You can also join us by zoom. Zoom link and information are on your right and in the calendar links above.

November 15, 2024 | Doug Gould, PhD

Identifying mechanism-based and mechanism agnostic interventions for disease of the extracellular matrix

 

Learn More About the Distinguished Speaker Series

Featured


Doug Gould, PhD
Doug Gould, PhD
  • Professor & Director of Research, Departments of Ophthalmology and Anatomy, University of California, San Francisco (UCSF)

Studying the biological functions of the extracellular matrix and its role in human disease

Our broad mission is to understand the biological functions of a specialized extracellular matrix structure called the Basement Membrane.

Our primary focus is a multi-system disorder that is caused by mutations in the genes encoding type IV collagen alpha 1 (COL4A1) and COL4A2.

Our goal is to understand the tissue-specific molecular mechanisms that underlie this syndrome and develop mechanism-based therapies that can prevent, reduce or delay disease in patients.

The Gould lab uses translational genetics to study the role that extracellular matrix proteins play in a multisystem connective tissue disorder caused by mutations in type IV collagens. Individuals with mutations in type IV collagen alpha 1 (COL4A1) or alpha 2 (COL4A2) often have a complex syndrome presenting with cerebrovascular, ocular, renal and muscular manifestations. Approximately one-third of these individuals have developmental defects of the eye leading to impaired vision or early onset glaucoma. The Gould lab uses genetic models to understand the molecular mechanisms underlying pathology in each organ that might represent therapeutic targets to prevent, reduce, or delay disease. Dr. Gould is the Director and Vice Chair for research and is dedicated trainee advocate and mentor with a commitment to inclusivity. The Gould lab provides research opportunities for Scholars interested in state-of-the-art genetic approaches, extracellular matrix biology, cell biology, physiology, biochemistry and advanced imaging.